2015-2025 Global Urological Cancer Drugs Market Research by Type, End-Use and Region (COVID-19 Version)

May 2024 | 150 pages | ID: 23A84C425FD5EN
99Strategy

Abstracts

SUMMARY

The global Urological Cancer Drugs market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.

Further key aspects of the report indicate that:

• Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
• Chapter 2: Global Production & Consumption Market by Type and End-Use
• Chapter 3: Europe Production & Consumption Market by Type and End-Use
• Chapter 4: America Production & Consumption Market by Type and End-Use
• Chapter 5: Asia Production & Consumption Market by Type and End-Use
• Chapter 6: Oceania Production & Consumption Market by Type and End-Use
• Chapter 7: Africa Production & Consumption Market by Type and End-Use
• Chapter 8: Global Market Forecast by Type, End-Use and Region
• Chapter 9: Company information, Sales, Cost, Margin, news etc.
• Chapter 10: Market Competition by Companies and Market Concentration Ratio
• Chapter 11: Market Impact by Coronavirus.
• Chapter 12: Industry Summary

Market Segment as follows:

Key Companies

• Novartis
• Pfizer
• Johnson & Johnson
• AstraZeneca
• Astellas
• Bristol-Myers Squibb
• Abbott Laboratories
• Celgene Corporation
• Dendreon Corporation
• Ferring Pharmaceuticals
• GlaxoSmithKline
• Indevus Pharmaceuticals Inc
• Ipsen
• Roche Healthcare
• Sanofi S.A.
• Tolmar Inc

Key Types

• Xofigo (Radium Ra 223 Dichloride)
• Jevtana (Cabazitaxel)
• Inlyta (Axitinib)
• Votrient (Pazopanib Hydrochloride)
• Sutent (Sunitinib Malate)
• Zytiga (Abiraterone Acetate)
• Xtandi (Enzalutamide)
• Opdivo (Nivolumab)
• Provenge (Sipuleucel-T)

Key End-Use

• Prostate Cancer
• Bladder Cancer
• Kidney Cancer
• Testicular Cancer

This report can be dispatched within 24-48 Hours.

Contents

CHAPTER 1 MARKET OVERVIEW

1.1 Market Definition and Segment
  1.1.1 Product Definition
  1.1.2 Product Type
  1.1.3 End-Use
  1.1.4 Marketing Channel
1.2 Major Regions
  1.2.1 Europe Market Size and Growth
Figure Europe Urological Cancer Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Urological Cancer Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.2 America Market Size and Growth
Figure America Urological Cancer Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Urological Cancer Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.3 Asia Market Size and Growth
Figure Asia Urological Cancer Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaUrological Cancer Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.4 Oceania Market Size and Growth
Figure Oceania Urological Cancer Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Urological Cancer Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.5 Africa Market Size and Growth
Figure Africa Urological Cancer Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Urological Cancer Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)

CHAPTER 2 GLOBAL MARKET SEGMENTATION

2.1 Global Production Overview
Table Global Urological Cancer Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Urological Cancer Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Urological Cancer Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Global Urological Cancer Drugs Revenue Share by Type in 2020 (Million USD)
Table Global Urological Cancer Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Global Urological Cancer Drugs Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Urological Cancer Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Urological Cancer Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Urological Cancer Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Urological Cancer Drugs Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Urological Cancer Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Global Urological Cancer Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 3 EUROPE MARKET SEGMENTATION

3.1 Europe Production Overview
Table Europe Urological Cancer Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Urological Cancer Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Urological Cancer Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Europe Urological Cancer Drugs Revenue Share by Type in 2020 (Million USD)
Table Europe Urological Cancer Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Europe Urological Cancer Drugs Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Urological Cancer Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Urological Cancer Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Urological Cancer Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Urological Cancer Drugs Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Urological Cancer Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Urological Cancer Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 4 AMERICA MARKET SEGMENTATION

4.1 America Production Overview
Table America Urological Cancer Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Urological Cancer Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Urological Cancer Drugs Revenue by Type, 2015-2020 (Million USD)
Figure America Urological Cancer Drugs Revenue Share by Type in 2020 (Million USD)
Table America Urological Cancer Drugs Production Volume by Type, 2015-2020 (Volume)
Figure America Urological Cancer Drugs Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Urological Cancer Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Urological Cancer Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table America Urological Cancer Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Urological Cancer Drugs Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Urological Cancer Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table America Urological Cancer Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 5 ASIA MARKET SEGMENTATION

5.1 Asia Production Overview
Table Asia Urological Cancer Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Urological Cancer Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Urological Cancer Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Asia Urological Cancer Drugs Revenue Share by Type in 2020 (Million USD)
Table Asia Urological Cancer Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Asia Urological Cancer Drugs Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Urological Cancer Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Urological Cancer Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Urological Cancer Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Urological Cancer Drugs Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Urological Cancer Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Urological Cancer Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 6 OCEANIA MARKET SEGMENTATION

6.1 Oceania Production Overview
Table Oceania Urological Cancer Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Urological Cancer Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Urological Cancer Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Urological Cancer Drugs Revenue Share by Type in 2020 (Million USD)
Table Oceania Urological Cancer Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Urological Cancer Drugs Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Urological Cancer Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Urological Cancer Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Urological Cancer Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Urological Cancer Drugs Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Urological Cancer Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Urological Cancer Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 7 AFRICA MARKET SEGMENTATION

7.1 Africa Production Overview
Table Africa Urological Cancer Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Urological Cancer Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Urological Cancer Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Africa Urological Cancer Drugs Revenue Share by Type in 2020 (Million USD)
Table Africa Urological Cancer Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Africa Urological Cancer Drugs Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Urological Cancer Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Urological Cancer Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Urological Cancer Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Urological Cancer Drugs Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Urological Cancer Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Urological Cancer Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 8 GLOBAL MARKET FORECAST

8.1 Global Urological Cancer Drugs Production Forecast
Figure Global Urological Cancer Drugs Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Urological Cancer Drugs Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Urological Cancer Drugs Forecast by Type
Table Global Urological Cancer Drugs Revenue by Type, 2020E-2025F (Million USD)
Figure Global Urological Cancer Drugs Revenue Share by Type in 2025 (Million USD)
Table Global Urological Cancer Drugs Production Volume by Type, 2020E-2025F (Volume)
Figure Global Urological Cancer Drugs Production Volume Share by Type in 2025 (Volume)
8.3 Global Urological Cancer Drugs Forecast by End-Use (2020E-2025F)
Table Global Urological Cancer Drugs Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Urological Cancer Drugs Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Urological Cancer Drugs Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Urological Cancer Drugs Forecast by Region (2020E-2025F)
Table Global Urological Cancer Drugs Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Urological Cancer Drugs Consumption Value Share by Region in 2025 (Million USD)
Table Global Urological Cancer Drugs Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Urological Cancer Drugs Consumption Volume Share by Region in 2025 (Volume)

CHAPTER 9 GLOBAL MAJOR COMPANIES LIST

9.1 Novartis
  9.1.1 Novartis Profile
Table Novartis Overview List
  9.1.2 Novartis Products & Services
  9.1.3 Novartis Company Dynamics & News
  9.1.4 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Pfizer
  9.2.1 Pfizer Profile
Table Pfizer Overview List
  9.2.2 Pfizer Products & Services
  9.2.3 Pfizer Company Dynamics & News
  9.2.4 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Johnson & Johnson
  9.3.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
  9.3.2 Johnson & Johnson Products & Services
  9.3.3 Johnson & Johnson Company Dynamics & News
  9.3.4 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 AstraZeneca
  9.4.1 AstraZeneca Profile
Table AstraZeneca Overview List
  9.4.2 AstraZeneca Products & Services
  9.4.3 AstraZeneca Company Dynamics & News
  9.4.4 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Astellas
  9.5.1 Astellas Profile
Table Astellas Overview List
  9.5.2 Astellas Products & Services
  9.5.3 Astellas Company Dynamics & News
  9.5.4 Astellas Business Operation Conditions
Table Business Operation of Astellas (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Bristol-Myers Squibb
  9.6.1 Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Overview List
  9.6.2 Bristol-Myers Squibb Products & Services
  9.6.3 Bristol-Myers Squibb Company Dynamics & News
  9.6.4 Bristol-Myers Squibb Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Abbott Laboratories
  9.7.1 Abbott Laboratories Profile
Table Abbott Laboratories Overview List
  9.7.2 Abbott Laboratories Products & Services
  9.7.3 Abbott Laboratories Company Dynamics & News
  9.7.4 Abbott Laboratories Business Operation Conditions
Table Business Operation of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Celgene Corporation
  9.8.1 Celgene Corporation Profile
Table Celgene Corporation Overview List
  9.8.2 Celgene Corporation Products & Services
  9.8.3 Celgene Corporation Company Dynamics & News
  9.8.4 Celgene Corporation Business Operation Conditions
Table Business Operation of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Dendreon Corporation
  9.9.1 Dendreon Corporation Profile
Table Dendreon Corporation Overview List
  9.9.2 Dendreon Corporation Products & Services
  9.9.3 Dendreon Corporation Company Dynamics & News
  9.9.4 Dendreon Corporation Business Operation Conditions
Table Business Operation of Dendreon Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Ferring Pharmaceuticals
  9.10.1 Ferring Pharmaceuticals Profile
Table Ferring Pharmaceuticals Overview List
  9.10.2 Ferring Pharmaceuticals Products & Services
  9.10.3 Ferring Pharmaceuticals Company Dynamics & News
  9.10.4 Ferring Pharmaceuticals Business Operation Conditions
Table Business Operation of Ferring Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 GlaxoSmithKline
  9.11.1 GlaxoSmithKline Profile
Table GlaxoSmithKline Overview List
  9.11.2 GlaxoSmithKline Products & Services
  9.11.3 GlaxoSmithKline Company Dynamics & News
  9.11.4 GlaxoSmithKline Business Operation Conditions
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Indevus Pharmaceuticals Inc
  9.12.1 Indevus Pharmaceuticals Inc Profile
Table Indevus Pharmaceuticals Inc Overview List
  9.12.2 Indevus Pharmaceuticals Inc Products & Services
  9.12.3 Indevus Pharmaceuticals Inc Company Dynamics & News
  9.12.4 Indevus Pharmaceuticals Inc Business Operation Conditions
Table Business Operation of Indevus Pharmaceuticals Inc (Sales Revenue, Cost, Gross Margin)
9.13 Ipsen
  9.13.1 Ipsen Profile
Table Ipsen Overview List
  9.13.2 Ipsen Products & Services
  9.13.3 Ipsen Company Dynamics & News
  9.13.4 Ipsen Business Operation Conditions
Table Business Operation of Ipsen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Roche Healthcare
  9.14.1 Roche Healthcare Profile
Table Roche Healthcare Overview List
  9.14.2 Roche Healthcare Products & Services
  9.14.3 Roche Healthcare Company Dynamics & News
  9.14.4 Roche Healthcare Business Operation Conditions
Table Business Operation of Roche Healthcare (Sales Revenue, Cost, Gross Margin)
9.15 Sanofi S.A.
  9.15.1 Sanofi S.A. Profile
Table Sanofi S.A. Overview List
  9.15.2 Sanofi S.A. Products & Services
  9.15.3 Sanofi S.A. Company Dynamics & News
  9.15.4 Sanofi S.A. Business Operation Conditions
Table Business Operation of Sanofi S.A. (Sales Revenue, Cost, Gross Margin)
9.16 Tolmar Inc
  9.16.1 Tolmar Inc Profile
Table Tolmar Inc Overview List
  9.16.2 Tolmar Inc Products & Services
  9.16.3 Tolmar Inc Company Dynamics & News
  9.16.4 Tolmar Inc Business Operation Conditions
Table Business Operation of Tolmar Inc (Sales Revenue, Cost, Gross Margin)

PART 10 MARKET COMPETITION

10.1 Key Company Market Share
Table Global Urological Cancer Drugs Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Urological Cancer Drugs Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Urological Cancer Drugs Sales Volume by Companies, 2015-2020E (Volume)
Table Global Urological Cancer Drugs Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Urological Cancer Drugs Market Concentration Ratio in 2020E
Figure America Urological Cancer Drugs Market Concentration Ratio in 2020E
Figure Asia Urological Cancer Drugs Market Concentration Ratio in 2020E
Figure Oceania Urological Cancer Drugs Market Concentration Ratio in 2020E
Figure Africa Urological Cancer Drugs Market Concentration Ratio in 2020E

PART 11 CORONAVIRUS IMPACT ON UROLOGICAL CANCER DRUGS INDUSTRY

11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment

PART 12 UROLOGICAL CANCER DRUGS INDUSTRY SUMMARY & CONCLUSION

List Of Tables

LIST OF TABLES
Table Global Urological Cancer Drugs Revenue by Type, 2015-2020 (Million USD)
Table Global Urological Cancer Drugs Production Volume by Type, 2015-2020 (Volume)
Table Global Urological Cancer Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Urological Cancer Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Urological Cancer Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Global Urological Cancer Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Urological Cancer Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Urological Cancer Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Urological Cancer Drugs Revenue by Type, 2015-2020 (Million USD)
Table Europe Urological Cancer Drugs Production Volume by Type, 2015-2020 (Volume)
Table Europe Urological Cancer Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Urological Cancer Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Urological Cancer Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Urological Cancer Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table America Urological Cancer Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Urological Cancer Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Urological Cancer Drugs Revenue by Type, 2015-2020 (Million USD)
Table America Urological Cancer Drugs Production Volume by Type, 2015-2020 (Volume)
Table America Urological Cancer Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Urological Cancer Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Urological Cancer Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table America Urological Cancer Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Urological Cancer Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Urological Cancer Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Urological Cancer Drugs Revenue by Type, 2015-2020 (Million USD)
Table Asia Urological Cancer Drugs Production Volume by Type, 2015-2020 (Volume)
Table Asia Urological Cancer Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Urological Cancer Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Urological Cancer Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Urological Cancer Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Urological Cancer Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Urological Cancer Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Urological Cancer Drugs Revenue by Type, 2015-2020 (Million USD)
Table Oceania Urological Cancer Drugs Production Volume by Type, 2015-2020 (Volume)
Table Oceania Urological Cancer Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Urological Cancer Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Urological Cancer Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Urological Cancer Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Urological Cancer Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Urological Cancer Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Urological Cancer Drugs Revenue by Type, 2015-2020 (Million USD)
Table Africa Urological Cancer Drugs Production Volume by Type, 2015-2020 (Volume)
Table Africa Urological Cancer Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Urological Cancer Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Urological Cancer Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Urological Cancer Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Global Urological Cancer Drugs Revenue by Type, 2020E-2025F (Million USD)
Table Global Urological Cancer Drugs Production Volume by Type, 2020E-2025F (Volume)
Table Global Urological Cancer Drugs Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Urological Cancer Drugs Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Urological Cancer Drugs Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Urological Cancer Drugs Consumption Volume by Region, 2020E-2025F (Volume)
Table Novartis Overview List
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Astellas Overview List
Table Business Operation of Astellas (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbott Laboratories Overview List
Table Business Operation of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celgene Corporation Overview List
Table Business Operation of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dendreon Corporation Overview List
Table Business Operation of Dendreon Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ferring Pharmaceuticals Overview List
Table Business Operation of Ferring Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Indevus Pharmaceuticals Inc Overview List
Table Business Operation of Indevus Pharmaceuticals Inc (Sales Revenue, Cost, Gross Margin)
Table Ipsen Overview List
Table Business Operation of Ipsen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Healthcare Overview List
Table Business Operation of Roche Healthcare (Sales Revenue, Cost, Gross Margin)
Table Sanofi S.A. Overview List
Table Business Operation of Sanofi S.A. (Sales Revenue, Cost, Gross Margin)
Table Tolmar Inc Overview List
Table Business Operation of Tolmar Inc (Sales Revenue, Cost, Gross Margin)
Table Global Urological Cancer Drugs Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Urological Cancer Drugs Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Urological Cancer Drugs Sales Volume by Companies, 2015-2020E (Volume)
Table Global Urological Cancer Drugs Sales Volume Share by Companies, 2015-2020E (Volume)

List Of Figures

LIST OF FIGURES
Figure Europe Urological Cancer Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Urological Cancer Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Urological Cancer Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Urological Cancer Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Urological Cancer Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaUrological Cancer Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Urological Cancer Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Urological Cancer Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Urological Cancer Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Urological Cancer Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Urological Cancer Drugs Revenue Share by Type in 2020 (Million USD)
Figure Global Urological Cancer Drugs Production Volume Share by Type in 2020 (Volume)
Figure Global Urological Cancer Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Urological Cancer Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Urological Cancer Drugs Revenue Share by Type in 2020 (Million USD)
Figure Europe Urological Cancer Drugs Production Volume Share by Type in 2020 (Volume)
Figure Europe Urological Cancer Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Urological Cancer Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Urological Cancer Drugs Revenue Share by Type in 2020 (Million USD)
Figure America Urological Cancer Drugs Production Volume Share by Type in 2020 (Volume)
Figure America Urological Cancer Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Urological Cancer Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Urological Cancer Drugs Revenue Share by Type in 2020 (Million USD)
Figure Asia Urological Cancer Drugs Production Volume Share by Type in 2020 (Volume)
Figure Asia Urological Cancer Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Urological Cancer Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Urological Cancer Drugs Revenue Share by Type in 2020 (Million USD)
Figure Oceania Urological Cancer Drugs Production Volume Share by Type in 2020 (Volume)
Figure Oceania Urological Cancer Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Urological Cancer Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Urological Cancer Drugs Revenue Share by Type in 2020 (Million USD)
Figure Africa Urological Cancer Drugs Production Volume Share by Type in 2020 (Volume)
Figure Africa Urological Cancer Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Urological Cancer Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Urological Cancer Drugs Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Urological Cancer Drugs Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Urological Cancer Drugs Revenue Share by Type in 2025 (Million USD)
Figure Global Urological Cancer Drugs Production Volume Share by Type in 2025 (Volume)
Figure Global Urological Cancer Drugs Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Urological Cancer Drugs Consumption Value Share by Region in 2025 (Million USD)
Figure Global Urological Cancer Drugs Consumption Volume Share by Region in 2025 (Volume)